SHP2 deficiency promotes Staphylococcus aureus pneumonia following influenza infection
- PMID: 31782850
- PMCID: PMC6985656
- DOI: 10.1111/cpr.12721
SHP2 deficiency promotes Staphylococcus aureus pneumonia following influenza infection
Abstract
Objectives: Secondary bacterial pneumonia is common following influenza infection. However, it remains unclear about the underlying molecular mechanisms.
Materials and methods: We established a mouse model of post-influenza S aureus pneumonia using conditional Shp2 knockout mice (LysMCre/+ :Shp2flox/flox ). The survival, bacterial clearance, pulmonary histology, phenotype of macrophages, and expression of type I interferons and chemokines were assessed between SHP2 deletion and control mice (Shp2flox/flox ). We infused additional KC and MIP-2 to examine the reconstitution of antibacterial immune response in LysMCre/+ :Shp2flox/flox mice. The effect of SHP2 on signal molecules including MAPKs (JNK, p38 and Erk1/2), NF-κB p65 and IRF3 was further detected.
Results: LysMCre/+ :Shp2flox/flox mice displayed impaired antibacterial immunity and high mortality compared with control mice in post-influenza S aureus pneumonia. The attenuated antibacterial ability was associated with the induction of type I interferon and suppression of chemo-attractants KC and MIP-2, which reduced the infiltration of neutrophils into the lung upon secondary bacterial invasion. In additional, Shp2 knockout mice displayed enhanced polarization to alternatively activated macrophages (M2 phenotype). Further in vitro analyses consistently demonstrated that SHP2-deficient macrophages were skewed towards an M2 phenotype and had a decreased antibacterial capacity. Moreover, SHP2 modulated the inflammatory response to secondary bacterial infection via interfering with NF-κB and IRF3 signalling in macrophages.
Conclusions: Our findings reveal that the SHP2 expression enhances the host immune response and prompts bacterial clearance in post-influenza S aureus pneumonia.
Keywords: chemo-attractants; inflammatory response; macrophage polarization; protein-tyrosine phosphatase SHP2; secondary bacterial pneumonia; type I interferon.
© 2019 The Authors. Cell Proliferation Published by John Wiley & Sons Ltd.
Conflict of interest statement
The authors declare they have no conflict of interest.
Figures





References
-
- Beveridge WI. The chronicle of influenza epidemics. Hist Philos Life Sci. 1991;13(2):223‐234. - PubMed
-
- Potter CW. A history of influenza. J Appl Microbiol. 2001;91(4):572‐579. - PubMed
-
- Dawood FS, Iuliano AD, Reed C, et al. Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study. Lancet Infect Dis. 2012;12(9):687‐695. - PubMed
-
- Finelli L, Fiore A, Dhara R, et al. Influenza‐associated pediatric mortality in the United States: increase of Staphylococcus aureus coinfection. Pediatrics. 2008;122(4):805‐811. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials
Miscellaneous